Shi, Y., Li, B., Liu, C., Jia, H., Niu, N., Qiu, X., Guan, J., Sun, L., Chen, G., Liu, J., Wang, F., Xu, N. (2025). Dalpiciclib combined with chidamide and letrozole as neoadjuvant therapy for HR-positive, HER2-negative early or locally advanced breast cancer: A single-arm, prospective, exploratory clinical study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e12593